Tradestie Institutional Equity Comparison Engine

DRIO vs CLPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DRIO Overall Edge

DRIO Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DarioHealth Corp. Common Stock (DRIO) driven by superior Valuation, Options & Structure while CLPT counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, DRIO trades at 10.6x Forward P/E with -142.7% operating margin (+6.1% YoY revenue) versus CLPT at 12.1x Forward P/E and -66.6% operating margin (+36.3% YoY). In options structure, DRIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CLPT sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DRIO
DRIO 10.6x vs CLPT 12.1x Fwd P/E
Growth & Margin Winner CLPT
Op Margin -142.7% vs -66.6% ยท YoY +6.1% vs +36.3%
Momentum & Technical Winner CLPT
1Y -90.0% vs -50.6% ยท 52W Pos 2% vs 0%
Options & Structure Winner DRIO
UNCLASSIFIED (N/A IV) vs BREAKDOWN (7th %ile IV)
DRIO NASDAQ
DarioHealth Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$1.32
-8.33% 1D
Market Cap $16.3M
1M Return -61.29%
1Y Return -90.02%
Forward P/E 10.6x
Unified AI Score
42.2 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 55.0
CLPT NASDAQ
ClearPoint Neuro, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$6.91
-5.47% 1D
Market Cap $234.3M
1M Return -25.3%
1Y Return -50.61%
Forward P/E 12.1x
Unified AI Score
40.4 / 100 SELL
Tech 25.0 Fund 48.0 Flow 65.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DRIO -90.02% CLPT -50.61% Spread: +39.96 pp (CLPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DRIO TTM Op. Margin: -142.7% CLPT TTM Op. Margin: -66.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DRIO vs CLPT. Trailing 12-month operating profitability (DRIO -142.7% vs CLPT -66.6%) and valuation multiples (DRIO 10.6x vs CLPT 12.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DRIO (5) vs CLPT (5)
Institutional Metric DRIO CLPT Criterion Row Winner
Market Capitalization Scale $16.3M $234.3M Larger Scale CLPT
Trailing P/E Ratio Valuation 10.6x 12.1x Lower Multiple DRIO
Forward P/E Ratio Valuation 10.6x 12.1x Lower Multiple DRIO
Revenue Growth (YoY) Growth +6.1% +36.3% Higher Growth CLPT
Operating Margin (TTM) Profitability -142.7% -66.6% Higher Margin CLPT
Net Profit Margin Profitability -159.9% -79.4% Higher Margin CLPT
Return on Equity (ROE) Capital Efficiency -46.6% -167.5% Higher ROE DRIO
52-Week Range Position Momentum 2% ($1โ€“$15) 0% ($7โ€“$20) Stronger Trend DRIO
Beta / 30D Volatility Risk Regime 0.45ฮฒ ยท 182% Vol 1.91ฮฒ ยท 86% Vol Lower Realized Risk CLPT
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 40.4 / 100 (SELL) Higher Composite DRIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DRIO vs CLPT Buy Guide
DRIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DRIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CLPT BREAKDOWN
102d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live CLPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DRIO nor CLPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.